{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:59:13Z","timestamp":1788483553736,"version":"build-2803163510"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.18632\/aging.206020","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:38:40Z","timestamp":1721313520000},"page":"11373-11384","source":"Crossref","is-referenced-by-count":12,"title":["High expression of circulating exosomal PD-L1 contributes to immune escape of hepatocellular carcinoma and immune clearance of chronic hepatitis B"],"prefix":"10.18632","volume":"16","author":[{"given":"Xiaoqing","family":"Lin","sequence":"first","affiliation":[{"name":"Wenzhou Central Hospital, Dingli Clinical College of Wenzhou Medical University, Wenzhou Sixth People\u2019s Hospital, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Tang","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiupeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjing","family":"Xing","sequence":"additional","affiliation":[{"name":"Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.","volume":"6","author":"Liu","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"39","author":"Qi","year":"2019","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.","volume":"15","author":"Thung","year":"2017","journal-title":"Gastroenterology"},{"key":"4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.","volume":"16","author":"Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu","year":"2017","journal-title":"Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.21037\/tgh.2018.10.16","article-title":"Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.","volume":"3","author":"Cheung","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"key":"6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jconrel.2022.11.050","article-title":"Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche.","volume":"35","author":"Liu","year":"2023","journal-title":"J Control Release"},{"key":"7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity.","volume":"187","author":"Yu","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41419-018-0534-9","article-title":"HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK\/ERK signalling pathway.","volume":"9","author":"Guo","year":"2018","journal-title":"Cell Death Dis"},{"key":"9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.28549","article-title":"Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans","volume":"6","author":"Yin","year":"2016","journal-title":"Hepatology"},{"key":"10","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0168-8278(17)30416-6","article-title":"Tumor derived exsomes mediate tumor infiltrating NK-cell dysfunction in patients with hepatocellular carcinoma via TGF-\u03b2\/SMAD pathway.","volume":"6","author":"Shao","year":"2017","journal-title":"J Hepatol"},{"key":"11","doi-asserted-by":"publisher","first-page":"2103943","DOI":"10.1155\/2019\/2103943","article-title":"Exosomes Modulate the Viral Replication and Host Immune Responses in HBV Infection.","volume":"201","author":"Chen","year":"2019","journal-title":"Biomed Res Int"},{"key":"12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","article-title":"Roles of PD-1\/PD-L1 Pathway: Signaling, Cancer, and Beyond.","volume":"124","author":"Xu","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory.","volume":"17","author":"Blelloch","year":"2019","journal-title":"Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","article-title":"The importance of exosomal PDL1 in tumour immune evasion.","volume":"2","author":"Freeman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3760\/cma.j.issn.1007-3418.2015.12.002","article-title":"Chinese Society of Hepatology, and Chinese Medical Association, and Chinese Society of Infectious Diseases, and Chinese Medical Association.","volume":"2","author":"Lai","year":"2015","journal-title":"[The guideline of prevention and treatment for chronic hepatitis B: a 2015 update]"},{"key":"16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.19538\/j.cjps.issn1005-2208.2020.02.01","article-title":"Standardization for diagnosis and treatment of primary hepatic carcinom.","volume":"4","author":"Bureau of Medical Administration, and National Health Commission of the People\u2019s Republic of China","year":"2020","journal-title":"Chinese Journal of Practical Surgery"},{"key":"17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer.","volume":"5","author":"Nam","year":"2019","journal-title":"Exp Mol Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"569219","DOI":"10.3389\/fcell.2020.569219","article-title":"Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies.","volume":"8","author":"Liang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.2741\/4846","article-title":"The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis.","volume":"2","author":"Moller","year":"2020","journal-title":"Front Biosci (Landmark Ed)"},{"key":"20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcancer.2017.02.006","article-title":"The role of exosomes in cancer metastasis.","volume":"4","author":"Skvortsova","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of Exosome Composition.","volume":"17","author":"Rome","year":"2019","journal-title":"Cell"},{"key":"22","doi-asserted-by":"publisher","first-page":"e0205886","DOI":"10.1371\/journal.pone.0205886","article-title":"The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes.","volume":"1","author":"Kotani","year":"2018","journal-title":"PLoS One"},{"key":"23","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1074\/jbc.RA120.014317","article-title":"Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model.","volume":"29","author":"Kotani","year":"2020","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1002\/jcp.30299","article-title":"PD-L1 overexpression conveys tolerance of mesenchymal stem cell-derived cardiomyocyte-like cells in an allogeneic mouse model.","volume":"23","author":"Abediankenari","year":"2021","journal-title":"J Cell Physiol"},{"key":"25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver.","volume":"3","author":"Jenne","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","article-title":"Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.","volume":"15","author":"Pan","year":"2017","journal-title":"Gastroenterology"},{"key":"27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-017-0180-7","article-title":"14-3-3\u03b6 delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis"},{"key":"28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.","volume":"2","author":"Becher","year":"2018","journal-title":"Nat Med"},{"key":"29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/tlcr.2017.03.01","article-title":"Current state of immunotherapy for non-small cell lung cancer.","volume":"6","author":"Aisner","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.","volume":"38","author":"de Castro","year":"2016","journal-title":"Lancet"},{"key":"31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pathol.2020.10.007","article-title":"Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.","volume":"5","author":"Gupta","year":"2021","journal-title":"Pathology"},{"key":"32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12967-020-02469-8","article-title":"Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8T cells in hepatocellular carcinoma using multiplex quantitative analysis.","volume":"1","author":"Xia","year":"2020","journal-title":"J Transl Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"e00058","DOI":"10.14309\/ctg.0000000000000058","article-title":"Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1\/Programmed Death-L1 Treatment.","volume":"1","author":"Decaens","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/diagnostics11101875","article-title":"Assessing PD-L1 Expression Level via Preoperative MRI in HCC Based on Integrating Deep Learning and Radiomics Features.","volume":"1","author":"Yang","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12967-019-2101-2","article-title":"Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.","volume":"1","author":"Liu","year":"2019","journal-title":"J Transl Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.","volume":"56","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"37","doi-asserted-by":"publisher","first-page":"1710899","DOI":"10.1080\/20013078.2019.1710899","article-title":"Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients.","volume":"9","author":"Gobbo","year":"2020","journal-title":"J Extracell Vesicles"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:37:53Z","timestamp":1722879473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7,31]]}},"alternative-id":["206020","39028365"],"URL":"https:\/\/doi.org\/10.18632\/aging.206020","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}